A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

NCT01838317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Pancreas

Interventions

DRUG: Pioglitazone

Sponsor

University of Texas Southwestern Medical Center